Biggest News Aggregation in the World
📰 Vorpacept News

Vorpacept News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Vorpacept . Real-time updates on events, politics, business and more.

ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer

Immuno-oncology company ALX Oncology Holdings Inc. (ALXO) announced Tuesday positive prespecified interim Phase 2 data from its ASPEN-06 clinical trial, a randomized multi-center international study evaluating evorpacept, the Company's CD47 blocking therapeutic, in combination with trastuzumab, CYRAMZA (ramucirumab) and paclitaxel for the treatment of patients with HER2-positive gastric/gastroesophageal junction (GEJ) cancer.
Oncology Holdings Inc Alx Oncology Vorpacept Mmuno Oncology Company Alx Spen 06 Clinical Trial D47 Blocking Therapeutic

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science